Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Soluble epoxide hydrolase inhibition restores pro-resolving lipid mediators and reduces inflammation in localized provoked vulvodynia.
Journal: Frontiers in pharmacology
Published: November 07, 2025
TGF-β drives myofibroblast activation and inflammatory mediator production in vulvar lichen sclerosus.
Journal: AJOG global reports
Published: July 21, 2025
ASCCP Clinical Consensus: Screening Recommendations for Clear Cell Adenocarcinomas in People Exposed to DES In Utero.
Journal: Journal of lower genital tract disease
Published: May 24, 2025
A cautionary tale: Non-steroidal anti-inflammatory drug use and localized provoked vulvodynia.
Journal: The journal of pain
Published: March 12, 2025
Inflammation, lipid dysregulation, and transient receptor potential cation channel subfamily V member 4 signaling perpetuate chronic vulvar pain.
Journal: Pain
Published: April 17, 2023
Human papillomavirus anogenital screening in solid organ transplant recipients: a narrative review.
Journal: Archives of gynecology and obstetrics
Published: August 04, 2021
Specialized Pro-resolving Mediators Reduce Pro-nociceptive Inflammatory Mediator Production in Models of Localized Provoked Vulvodynia.
Journal: The journal of pain
Published: November 20, 2020
Risk factors for wound complications in morbidly obese women undergoing primary cesarean delivery.
Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Published: January 12, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026